πŸ‡ΊπŸ‡Έ FDA
Patent

US 10238770

Reparative cell isolation and delivery

granted A61KA61K35/12A61P

Quick answer

US patent 10238770 (Reparative cell isolation and delivery) held by The Board of Regents of the University of Texas System expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K35/12, A61P, A61P1/00, A61P17/02